Briggs Morrison is Director of Codiak BioSciences, Inc.. Currently has a direct ownership of 4,761 shares of CDAK, which is worth approximately $47. The most recent transaction as insider was on Feb 17, 2021, when has been sold 4,761 shares (Common Stock) at a price of $21.0 per share, resulting in proceeds of $99,981. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 4.76K
0% 3M change
0% 12M change
Total Value Held $47

Briggs Morrison Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 17 2021
BUY
Open market or private purchase
$99,981 $21.0 p/Share
4,761 Added 50.0%
4,761 Common Stock

Also insider at

SNDX
Syndax Pharmaceuticals Inc Healthcare
HOWL
Werewolf Therapeutics, Inc. Healthcare
RPTX
Repare Therapeutics Inc. Healthcare
ARVN
ARVINAS, INC. Healthcare
SESN
Sesen Bio, Inc. Healthcare
BM

Briggs Morrison

Director
Waltham, MA

Track Institutional and Insider Activities on CDAK

Follow Codiak BioSciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CDAK shares.

Notify only if

Insider Trading

Get notified when an Codiak Bio Sciences, Inc. insider buys or sells CDAK shares.

Notify only if

News

Receive news related to Codiak BioSciences, Inc.

Track Activities on CDAK